Apellis Pharmaceuticals (APLS) Stock: Headed Up On Fast Track Designation

Apellis Pharmaceuticals Inc (NASDAQ: APLS) is having a great start to the trading session this morning, and for good reason. The company announced that it has received Fast Track designation from the FDA for one of its clinical candidates. As you could imagine, the news excited investors, pushing the stock on a run for the … Read more